A molecule that promotes cell growth, and is frequently increased in different types of tumors, can be restrained by a molecular version of handcuffs, raising the prospect of a new way of treating the disease, according to new research released February 15.
Cancer Research UK-funded scientists were able to lock up a protein called IGF2, which helps control growth in all normal cells but when over-produced makes cells grow too large and too fast. In humans, increased levels of IGF2 are associated with a higher relative risk of bowel cancer.
Scientists at Bristol University took mice with a genetic predisposition to bowel polyps, which can lead on to cancer, and used a molecule that binds strongly to IGF2 to capture it and rescue the mouse cells from its effects.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze